Profile

Jeffrey Rogers, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

31 Ratings
3 Comments
 

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, Surgical Sciences-Transplant

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-0548
Department: 336-716-0548

Email: jerogers@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., University of Pennsylvania, 1986
  • M.D., Albert Einstein College of Medicine, 1990
  • Residency, Montefiore Hosp/Med Ctr, 1995
  • Fellowship, Transplant Surgery, University of Pittsburgh Schoo, 1996
  • Fellowship, Transplantation Immunology, University of Pittsburgh Schoo, 1997
  • Fellowship, Transplant Surgery, University of Pittsburgh Schoo, 1999

Board Certifications

  • American Board of Surgery, Surgery

NPI Number

  • 1073598140
Jeffrey Rogers, M.D.

Doctor Rating

4.8 out of 5

31 Ratings
3 Comments
 

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, Surgical Sciences-Transplant
Institute for Regenerative Medicine

Research Interests

Pancreas Transplantation; Kidney Transplantation; Graft Rejection; Tissue Donors; Portal Vein
More »

Contact Information

Academic: 336-716-0548 | Department: 336-716-0548

Email: jerogers@wakehealth.edu

Recent Publications

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.. Expert Rev Clin Immunol. 2016;12(2):169-182.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.. Ann Surg. 2016;264(1):169-179.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):43.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):44.

Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R.. Am J Transplant. 2016;16(Suppl 1):53.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.. J Nephrol. 2015;28(3):379-385.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Farney AC, Rogers J, Orlando G, Stratta RJ.. Curr Opin Organ Transplant. 2015;20(1):103-107.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Prospect for kidney bioengineering: shortcomings of the status quo. Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.. Expert Opin Biol Ther. 2015;15(4):547-558.

Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G.. Am J Transplant. 2015;15(Suppl 1):49.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Orlando G, Urbani L, Cravedi P, Sordi V, Guoguang N, Citro A, Mcquilling J, Farney A, Iskandar S, Rogers J, Stratta R, Opara E, Piemonti L, Soker S, De Coppi P, Petrosyan A.. Tissue Eng Part A. 2015;21(Suppl 1):S141.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new generation bioartificial endocrine pancreas [abstract]. Orlando G, Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas EMA, Sordi V, Purroy C, Niu GG, Mcquilling JP, Sivanandane S, Farney AC, Iskandar SS, Rogers J, Stratta RJ, Opara EC, Piemonti L, Soker S, De Coppi P.. Transpl Int. 2015;28(Suppl 4):129.

Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ.. Clin Transplant. 2014;28(1):16-26.

Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74-75.

Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Stratta RJ, Farney AC, Rogers J, Orlando G.. Expert Rev Clin Immunol. 2014;10(1):117-132.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):855.

Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

7 year results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Farney A, Rogers J, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):90.

ECM scaffolds from discarded human kidneys perform as bio-system when seeded with multipotent progenitor cells [abstract]. Orlando G, Sedrakyan S, Peloso A, Wang Z, Farney A, Delario G, Rogers J, Stratta R, Soker S, Perin L.. Transplantation. 2014;98(Suppl 1):304.

ECM scaffolds from discarded human kidneys retain growth factors along with intact microstructural morphologies of the innate vasculature [abstract]. Peloso A, Katari R, Booth C, Wang Z, Zambon J, Farney A, Rogers J, Delario G, Stratta R, Soker S, Orlando G.. Transplantation. 2014;98(Suppl 1):304.

Pancreas transplantation in African American compared to non African American patients: does recipient ethnicity influence outcomes? [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

Similar results with solitary pancreas transplantation compared to simultaneous pancreas-kidney transplantation in the new millennium [abstract]. Rogers J, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Transplantation. 2014;98(Suppl 1):854.

Does donor ethnicity influence kidney transplant outcome after simultaneous kidney-pancreas transplantation? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Winfrey S, Uloko V, Bodner J, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Freedman B, Stratta R.. Transplantation. 2014;98(Suppl 1):861.

Osseus metaplasia in kidney allografts as a paradigm of regenerative medicine principles. Sanders BP, Orlando G, Peloso A, Katari RS, Iskandar SS, Farney AC, Rogers J, Soker S, Stratta RJ.. Exp Clin Transplant. 2014;12(4):371-373.

Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):860.

What we do and don't understand about pancreas graft failure [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Bodner J, Rogers J.. Transplantation. 2014;98(Suppl 1):863.

Expanded criteria donors: the end of an era [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Rogers J.. Transplantation. 2014;98(Suppl 1):654.

Experience with deceased donor kidney transplantation in 114 septuagenarians [abstract]. Stratta R, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Rogers J.. Transplantation. 2014;98(Suppl 1):600.

5 year results of a prospective, randomized single center study of alemtuzumab compared to rabbit anti-thymocyte gobulin induction in simultaneous kidney-pancreas transplantation [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Farney A.. Transplantation. 2014;98(Suppl 1):215.

Dual kidney transplants from adult marginal donors: double or nothing [abstract]. Stratta R, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Iskandar S, Gautreaux M, Farney A.. Transplantation. 2014;98(Suppl 1):595-596.

Similar results with solitary pancreas transplantation compared with simultaneous pancreas-kidney transplantation in the new millennium. Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Rogers J.. Transplant Proc. 2014;46(6):1924-1927.

Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin. Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.. Expert Opin Biol Ther. 2014;14(12):1723-1730.

5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation. Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC.. Transplant Proc. 2014;46(6):1928-1931.

Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. Clin Transplant. 2014;28(12):1372-1382.

Pancreas transplantation: the Wake Forest experience in the new millennium. Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ.. World J Diabetes. 2014;5(6):951-961.

Retrieval of the pancreas allograft for whole-organ transplantation. Fridell JA, Powelson JA, Kubal CA, Burke GW, Sageshima J, Rogers J, Stratta RJ.. Clin Transplant. 2014;28(12):1313-1330.

Dual kidney transplants from marginal donors: double or nothing [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta RJ.. Am J Transplant. 2013;13(Suppl 2):72.

Effect of donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants [abstract]. Farooq U, Al-Shraideh Y, Al-Geizawi S, Orlando G, Rogers J, Farney A, Stratta RJ.. Am J Transplant. 2013;13(Suppl 2):73-74.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Sciences-Transplant

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery
Jeffrey Rogers, M.D.

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, Surgical Sciences-Transplant
Institute for Regenerative Medicine

Doctor Rating

4.8 out of 5

Jeffrey Rogers, M.D.31 Ratings
3 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.8
Wait time at clinic
4.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/10/2016

I enjoyed meeting *Dr. Roger and staff all were very helpful about my kidney condition.

3/9/2016

*D. Rogers did my surgery. It was great to see him 6 years later.

10/5/2015

We were very impressed with the dr.'s NP's so far awesome!

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Comprehensive Cancer Centers National Designation is RenewedMagnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.